These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2409790)

  • 21. Immunohistochemical demonstration of neuron-specific enolase in gynecologic malignant tumors.
    Inoue M; Ueda G; Nakajima T
    Cancer; 1985 Apr; 55(8):1686-90. PubMed ID: 2983859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.
    Thomas P; Battifora H; Manderino GL; Patrick J
    Am J Clin Pathol; 1987 Aug; 88(2):146-52. PubMed ID: 3618548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
    Springall DR; Lackie P; Levene MM; Marangos PJ; Polak JM
    J Pathol; 1984 Aug; 143(4):259-65. PubMed ID: 6090626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of gamma-enolase as a tumor marker for lung cancer.
    Fujita K; Haimoto H; Imaizumi M; Abe T; Kato K
    Cancer; 1987 Aug; 60(3):362-9. PubMed ID: 3036329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The simultaneous evaluation of serum NSE as a tumor marker in lung cancer compared with serum CEA--high sensitivity and specificity defined in the TP-FP curve].
    Shimizu K; Nose I; Koga T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):472-8. PubMed ID: 3006595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuron-specific enolase as a new tumor marker].
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma.
    Notomi T; Morikawa J; Kato K; Tsuchida Y; Ohsawa R
    Tumour Biol; 1985; 6(1):57-66. PubMed ID: 3895369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron specific enolase in human small cell carcinoma cultures.
    Marangos PJ; Gazdar AF; Carney DN
    Cancer Lett; 1982 Jan; 15(1):67-71. PubMed ID: 6120757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
    Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
    Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
    Leader M; Collins M; Patel J; Henry K
    J Clin Pathol; 1986 Nov; 39(11):1186-92. PubMed ID: 3540015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.
    Splinter TA; Verkoelen CF; Vlastuin M; Kok TC; Rijksen G; Haglid KG; Boomsma F; van de Gaast A
    Br J Cancer; 1992 Dec; 66(6):1065-9. PubMed ID: 1333786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.
    Esscher T; Steinholtz L; Bergh J; Nöu E; Nilsson K; Påhlman S
    Thorax; 1985 Feb; 40(2):85-90. PubMed ID: 2983452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
    Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doubling time of neuron-specific enolase and survival in small cell lung cancer patients. Results of a preliminary analysis.
    Splinter TA; Cooper EH; Oosterom R; Peake MD; Brown DA; Kho GS
    Eur J Respir Dis Suppl; 1987; 149():37-44. PubMed ID: 3034646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum neuron-specific enolase in patients with lung cancer].
    Matsubara Y; Yasuda Y; Yagi K; Ike O; Aoki M; Miyamoto Y; Hatakenaka R; Ninomiya K; Funatsu T; Ikeda S
    Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1136-45. PubMed ID: 2999271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.